InsidersTradesSigma
Browse the detailed record of transactions filed by Griffith Donald J., Director. Insider active across 1 companies, notably Sonnet BioTherapeutics Holdings, Inc.. In total, 3 reports have been published. The latest transaction was disclosed on 25 May 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Griffith Donald J. serves as a Board Member at Sonnet BioTherapeutics Holdings, Inc. In this role, he contributes to governance and oversight of the company's activities, bringing his expertise in the biopharmaceutical sector.